Lanzul

Lansoprazole, the active ingredient in Lanzul, is a proton pump inhibitor presented as an oral dosage form for oral administration. It works by decreasing gastric acid production and is prescribed for the treatment and management of gastro‑oesophageal reflux disease, erosive esophagitis, peptic ulcer disease, and as part of Helicobacter pylori eradication regimens in adult and pediatric patients where appropriate.

GNH USA supplies Lanzul as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance and regulatory compliance.

Lansoprazole is a proton pump inhibitor used to reduce gastric acid production in several gastrointestinal disorders.

- Gastro‑oesophageal reflux disease (GERD): provides relief of heartburn and promotes healing of esophageal irritation. - Erosive esophagitis: accelerates healing of erosive lesions in the esophagus. - Peptic ulcer disease: facilitates ulcer healing and helps prevent recurrence. - Helicobacter pylori eradication (as part of combination therapy): improves eradication success when used with antibiotics.

Lansoprazole may cause a range of adverse reactions, which are generally classified by frequency and severity.

Common Side Effects: - Headache - Diarrhea - Nausea - Abdominal pain - Flatulence - Constipation - Dizziness

Serious or Rare Side Effects: - Severe allergic reactions such as anaphylaxis or angioedema - Clostridioides difficile‑associated diarrhea - Low magnesium levels (hypomagnesemia) with prolonged use - Increased risk of fractures (hip, wrist, spine) - Interstitial nephritis - Hepatic dysfunction including hepatitis

Before prescribing Lanzul, clinicians should consider several safety measures.

- Assess renal and hepatic function: adjust use in patients with severe impairment. - Monitor magnesium levels: prolonged therapy may lead to hypomagnesemia. - Avoid concomitant use with drugs that require gastric acidity for absorption, as efficacy may be reduced. - Use with caution in elderly patients due to an increased fracture risk. - Store at ambient temperature (below 25°C): keep in the original container, protect from moisture and light.

Lansoprazole can interact with a variety of medicines, affecting their efficacy or safety.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect. - Atazanavir or other protease inhibitors: decreased antiviral absorption. - Methotrexate: increased toxicity due to reduced renal clearance. - Warfarin: potential increase in INR and bleeding risk. - Ketoconazole: decreased antifungal absorption.

Moderate Interactions (Monitor Closely): - Digoxin: may increase serum concentrations. - Diazepam: enhanced sedation. - Iron salts: reduced iron absorption. - Vitamin B12: long‑term use may impair absorption.